TScan Therapeutics, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: TScan Therapeutics, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
TScan Therapeutics, Inc. Assets for the quarter ending September 30, 2024 was $348M, a 19.4% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$348M	+$56.6M	+19.4%	Sep 30, 2024	10-Q	2024-11-12
Q2 2024	$375M	+$57.9M	+18.3%	Jun 30, 2024	10-Q	2024-08-12
Q1 2024	$241M	+$67.3M	+38.7%	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$272M	+$73.1M	+36.7%	Dec 31, 2023	10-Q	2024-11-12
Q3 2023	$291M	+$126M	+76.1%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$317M	+$165M	+108%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$174M	+$5.37M	+3.19%	Mar 31, 2023	10-Q	2023-05-10
Q4 2022	$199M	+$11M	+5.84%	Dec 31, 2022	10-K	2024-03-06
Q3 2022	$165M	-$39.4M	-19.2%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$152M	+$22.4M	+17.2%	Jun 30, 2022	10-Q	2022-08-10
Q1 2022	$168M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$188M	+$138M	+278%	Dec 31, 2021	10-K	2023-03-08
Q3 2021	$205M			Sep 30, 2021	10-Q	2021-11-10
Q2 2021	$130M			Jun 30, 2021	10-Q	2021-08-19
Q4 2020	$49.7M			Dec 31, 2020	10-K	2022-03-09

* An asterisk sign (*) next to the value indicates that the value is likely invalid.